Defective Drug Warning: Heart Medication Multaq

The United States Food and Drug Administration (FDA) recently issued a warning to all people taking the prescription drug dronedarone, sold as Multaq and Sanofi-Aventis. 

After the FDA recently conducted a safety review of the drug, which is used in patients who suffer from atrial fibrillation, the organization discovered that the medication actually increased the risk of death, stroke, and heart failure in patients with permanent atrial fibrillation. The FDA asked the manufacturers of the drug to update their warning labels to reflect the fact that anyone with permanent AF should not take Multaq. The FDA also stated that those taking dronedarone should seek medical attention every three months and have an electrocardiogram in order to analyze their heart’s rhythm. 

Other Multaq side effects include diarrhea, weakness, nausea, rashes, abdominal pain, slowed heart rate, vomiting, and heartburn. Rarer but more serious side-effects include a significantly slower heart rate, lightheadedness, allergic reactions, liver failure, low levels of magnesium or potassium, and heart failure. 

If you believe that you or a loved one was seriously harmed by Multaq, dronedarone, or any other defective prescription drug, speak with a products liability attorney. The Indianapolis defective drug attorneys at Keller & Keller LLP can help you better understand dangerous drug lawsuits and whether you may deserve compensation. Call us today to schedule a free, private meeting with a knowledgeable attorney.  

Post A Comment